PROSTATE CANCER RESEARCH
Prostate Cancer Research aims to save lives and improve the quality of life for all those affected by prostate cancer through funding research and empowering patients.
Financial health, per its FY2025 accounts
The accounts state that total income increased by 6% to £5.2 million, while total expenditure rose to £6.1 million, resulting in a net decrease in reserves of approximately £880,000. General unrestricted reserves stood at £970,524 at year-end, which is below the charity's stated policy target of £1.7 million. The trustees confirmed adequate resources for the foreseeable future and the auditor reported no material uncertainties regarding going concern.
What the accounts disclose
“Our reserves policy has been being modified to adopt a risk-based approach requiring free reserves of £1.7 million to provide a stable foundation for delivering our strategic goals.” — page 9
“A debtor balance with PCR Inc of £744,000 has been written off at the year end. The balance represented grant expenditure and supporting costs incurred in the United States over a number of years to advance the objects of the charity.” — page 34
“grant and operational expenditures for our US subsidiary, PCR Inc., should be treated for accounting purposes consistently with our UK activities”
Structured financials (annual return, FY ending 31/03/2025)
Register events
- Received assets from another charity (14/08/2026)
- Received assets from another charity (11/07/2025)
- Received assets from another charity (20/12/2021)
Trustees
- Alex Davis
- Clare Phillips
- Jonathan Badger
- Karen Blyth
- Louisa Fleure
- MARCELLA ANGELA TURNER
- MARK CLARK
- Magnus Hibbert
- Neil Mackison
- Nicholas Jones
- Prof Simon Crabb
- Professor Philip Cornford
- Richard Collier
- Soeren Fryland Moeller
- Suman Shirodkar
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £5.2m | £6.1m |
| 31/03/2024 | £4.9m | £4.1m |
| 31/03/2023 | £3.0m | £3.5m |
| 31/03/2022 | £2.7m | £2.6m |
| 31/03/2021 | £1.1m | £1.9m |
Common questions
Is PROSTATE CANCER RESEARCH financially healthy?
Per its FY2025 accounts: The accounts state that total income increased by 6% to £5.2 million, while total expenditure rose to £6.1 million, resulting in a net decrease in reserves of approximately £880,000. General unrestricted reserves stood at £970,524 at year-end, which is below the charity's stated policy target of £1.7 million. The trustees confirmed adequate resources for the foreseeable future and the auditor reported no material uncertainties regarding going concern. Its FY2025 accounts were audited by Moore Kingston Smith LLP.
Who funds PROSTATE CANCER RESEARCH?
Funders whose own accounts filings name PROSTATE CANCER RESEARCH as a grant recipient include BREAST CANCER NOW, PHILIP KING CHARITABLE TRUST, PETER STORMONTH DARLING CHARITABLE TRUST, THE WILL CHARITABLE TRUST, THE CADOGAN CHARITY.
Known funders
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| The National Lottery Community Fund | 18/12/2024 | £496k | Empowering People with Prostate Cancer - Phase 2 |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| SANDRA CHARITABLE TRUST | 3 | £52k |
| CHRISTOS LAZARI FOUNDATION | 2 | £621k |
| THE PENNIES FOUNDATION | 2 | £496k |
| THE ORR MACKINTOSH FOUNDATION LIMITED | 2 | £364k |
| PEACOCK CHARITABLE TRUST | 2 | £288k |
| THE CATHERINE COOKSON CHARITABLE TRUST | 2 | £255k |
| The Trevor Hemmings Foundation | 2 | £250k |
| THE CONSTANCE TRAVIS CHARITABLE TRUST | 2 | £220k |
Charities like this
- PROSTATE CANCER UK
- THE PROSTATE PROJECT
- BOB CHAMPION CANCER TRUST
- YORKSHIRE CANCER RESEARCH
- PCASO PROSTATE CANCER SUPPORT ORGANISATION
- BREAST CANCER RESEARCH AID (BCRA)
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| PROSTATE CANCER RESEARCH | £5.2m | — | — | unclear | — | no doubt |
| PROSTATE CANCER UK | £45.5m | — | — | above | — | no doubt |
| THE PROSTATE PROJECT | £493k | — | 0 | unclear | — | no doubt |
| BOB CHAMPION CANCER TRUST | £555k | — | 0 | unclear | — | no doubt |
| YORKSHIRE CANCER RESEARCH | £27.7m | — | — | unclear | — | no doubt |
| PCASO PROSTATE CANCER SUPPORT ORGANISATION | £186k | — | 0 | unclear | — | no doubt |